Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: A fit for purpose approach

Biomarkers

Volumn 18, Issue 6, 2013, Pages 467-486

  Gregg, Evan O ^a   Minet, Emmanuel ^b   McEwan, Michael ^b  

^a ENI Limited   (United Kingdom)

^b BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Biomarker qualification; biomarker validation; comparative studies; tobacco products assessment

Indexed keywords

1,3 BUTADIENE; 2 CARBOXY 1 METHYLETHYLMERCAPTURIC ACID; 4 (METHYLNITROSOAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE; BIOLOGICAL MARKER; CADMIUM; DIHYDROXYBUTYL MERCAPTURIC ACID; N NITROSOANABASINE; N NITROSOANATABINE; NITROSAMINE; NITROSONORNICOTINE; PYRENE; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; GAS CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; TOBACCO; URINE LEVEL;

BIOLOGICAL MARKERS; HUMANS; SMOKING; TOBACCO;

EID: 84885339614     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.821523     Document Type: Article

References (189)

1. Abdel-Rahman SZ, Ammenheuser MM, Omiecinski CJ, et al. (2005). Variability in human sensitivity to 1, 3-butadiene: influence of polymorphisms in the 50-flanking region of the microsomal epoxide hydrolase gene (ephx1). Toxicol Sci 85:624-31.
2. Al-Zoughool M, Talaska G. (2006). 4-Aminobiphenyl n-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the udp-glucuronosyltransferase isoforms. J Appl Toxicol 26:524-32.
3. Ambrosone CB, Abrams SM, Gorlewska-Roberts K, Kadlubar FF. (2007). Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. Arch Biochem Biophys 464:169-75.
4. Anderson KE, Kliris J, Murphy L, et al. (2003). Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. Cancer Epidemiol Biomarkers Prev 12:1544-6.
5. Angelini S, Kumar R, Bermejo JL, et al. (2011). Exposure to low environmental levels of benzene: evaluation of micronucleus frequencies and s-phenylmercapturic acid excretion in relation to polymorphisms in genes encoding metabolic enzymes. Mutat Res 719: 7-13.
6. Angerer J, Ewers U, Wilhelm M. (2007). Human biomonitoring: state of the art. Int J Hyg Environ Health 210:201-28.
7. Arndt T. (2009). Urine-creatinine concentration as a marker of urine dilution: reflections using a cohort of 45, 000 samples. Forensic Sci Int 186:48-51.
8. Ashley DL, Burns DM, Djordjevic M, et al. (2007). The scientific basis of tobacco product regulation: report of a who study group. Geneva: World Health Organization.
9. Avila-Tang E, Al-Delaimy WK, Ashley DL, et al. (2013). Assessing secondhand smoke using biological markers. Tob Control 22:164-71.
10. Badawi AF, Hirvonen A, Bell DA, et al. (1995). Role of aromatic amine acetyltransferases, nat1 and nat2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 55: 5230-7.
11. Bao Z, He X-Y, Ding X, et al. (2005). Metabolism of nicotine and cotinine by human cytochrome p450 2a13. Drug Metab Dispos 33: 258-61.
12. Bartsch H, Caporaso N, Coda M, et al. (1990). Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst 82: 1826-31.
13. Berhane K, Widersten M, Engstrom A, et al. (1994). Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci USA 91:1480-4.
14. Berlin NI, Waldmann TA, Weissman SM. (1959). Life span of red blood cell. Physiol Rev 39:577-616.
15. Bernert JT, Jain RB, Pirkle JL, et al. (2005). Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. Nicotine Tob Res 7: 729-38.
16. Bernert JT, Pirkle JL, Xia Y, et al. (2010). Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure. Cancer Epidemiol Biomarkers Prev 19: 2969-77.
17. Bhat SH, Gelhaus SL, Mesaros C, et al. (2011). A new liquid chromatography/ mass spectrometry method for 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (nnal) in urine. Rapid Commun Mass Spectrom 25:115-21.
18. Biber A, Scherer G, Hoepfner I, et al. (1987). Determination of nicotine and cotinine in human serum and urine: an interlaboratory study. Toxicol Lett 35:45-52.
19. Breyer-Pfaff U, Martin H-J, Ernst M, Maser E. (2004). Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver. Drug Metab Dispos 32:915-22.
20. Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. (1988). Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci USA 85:9788-91.
21. Budiawan, EE. (2001). Cancer risk assessment for the environmental mutagen and carcinogen crotonaldehyde on the basis of td(50) and comparison with 1, n(2)-propanodeoxyguanosine adduct levels. Cancer Epidemiol Biomarkers Prev 10:883-8.
22. Burns DM, Dybing E, Gray N, et al. (2008). Mandated lowering of toxicants in cigarette smoke: a description of the world health organization tobreg proposal. Tob Control 17:132-41.
23. Bushey RT, Chen G, Blevins-Primeau AS, et al. (2011). Characterization of udp-glucuronosyltransferase 2a1 (ugt2a1) variants and their potential role in tobacco carcinogenesis. Pharmacogenet Genomics 21:55-65.
24. Butler MW, Fukui T, Salit J, et al. (2011). Modulation of cystatin a expression in human airway epithelium related to genotype, smoking, COPD, and lung cancer. Cancer Res 71:2572-81.
25. Carmella SG, Borukhova A, Akerkar SA, Hecht SS. (1997). Analysis of human urine for pyridine-n-oxide metabolites of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Cancer Epidemiol Biomarkers Prev 6:113-20.
26. Carmella SG, Chen M, Han S, et al. (2009). Effect of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol 22:734-41.
27. Carmella SG, Chen M, Zhang Y, et al. (2007). Quantitation of acroleinderived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem Res Toxicol 20:986-90.
28. Carmella SG, Le K-A, Hecht SS. (2004). Improved method for determination of 1-hydroxypyrene in human urine. Cancer Epidemiol Biomarkers Prev 13:1261-4.
29. Carmella SG, Le Ka K-a, Upadhyaya P, Hecht SS. (2002). Analysis of nand o-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (nnal) in human urine. Chem Res Toxicol 15:545-50.
30. Chau CH, Rixe O, McLeod H, Figg WD. (2008). Validation of analytic methods for biomarkers used in drug development. Clin Cancer Res 14:5967-76.
31. Chen CB, Hecht SS, McCoy GD, Hoffmann D. (1980). Assays for metabolic alpha-hydroxylation of n0-nitrosonornicotine and n-nitrosopyrrolidine and the influence of modifying factors. IARC Sci Publ 31:349-59.
32. Chen L, Wang M, Villalta PW, et al. (2007). Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. Chem Res Toxicol 20:108-13.
33. Chiang HC, Wang CY, Lee HL, Tsou TC. (2011). Metabolic effects of cyp2a6 and cyp2a13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (nnk)-induced gene mutation - a mammalian cell-based mutagenesis approach. Toxicol Appl Pharmacol 253:145-52.
34. Chuang C-Y, Chang C-C. (2007). Urinary 1-hydroxypyrene level relative to vehicle exhaust exposure mediated by metabolic enzyme polymorphisms. J Occup Health 49:140-51.
35. Chung FL, Chen HJ, Nath RG. (1996). Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 17:2105-11.
36. Church TR, Anderson KE, Le C, et al. (2010a). Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers. Biomarkers 15:345-52.
37. Church TR, Haznadar M, Geisser MS, et al. (2010b). Interaction of cyp1b1, cigarette-smoke carcinogen metabolism, and lung cancer risk. Int J Mol Epidemiol Genet 1:295-309.
38. Church TR, Anderson KE, Caporaso NE, et al. (2009). A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 18:260-6.
39. Cirillo M, Mellone M, De Santo NG. (1993). Can overnight urine replace 24-hour urine collection to measure urinary calcium in epidemiologic studies? Miner Electrolyte Metab 19:385-8.
40. Cote AM, Brown MA, Lam E, et al. (2008). Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review. Br Med J 336:1003-6.
41. Daly AK, Cholerton S, Armstrong M, Idle JR. (1994). Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 102:55-61.
42. Ding YS, Blount BC, Valentin-Blasini L, et al. (2009). Simultaneous determination of six mercapturic acid metabolites of volatile organic compounds in human urine. Chem Res Toxicol 22:1018-25.
43. Doolittle DJ, Rahn CA, Riccio E, et al. (1990). Comparative studies of the mutagenicity of urine from smokers and non-smokers on a controlled non-mutagenic diet. Food Chem Toxicol 28:639-46.
44. Doroshyenko O, Fuhr U, Kunz D, et al. (2009). In vivo role of cytochrome p450 2e1 and glutathione-s-transferase activity for acrylamide toxicokinetics in humans. Cancer Epidemiol Biomarkers Prev 18:433-43.
45. Dougherty D, Garte S, Barchowsky A, et al. (2008). Nqo1, mpo, cyp2e1, gstt1 and gstm1 polymorphisms and biological effects of benzene exposure - a literature review. Toxicol Lett 182:7-17.
46. Eckert E, Schmid K, Schaller B, et al. (2011). Mercapturic acids as metabolites of alkylating substances in urine samples of german inhabitants. Int J Hyg Environ Health 214:196-204.
47. Esterbauer H, Schaur RJ, Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-28.
48. Feng S, Roethig HJ, Liang Q, et al. (2006). Evaluation of urinary 1-hydroxypyrene, s-phenylmercapturic acid, trans, trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-20-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers 11:28-52.
49. Fennell TR, MacNeela JP, Morris RW, et al. (2000). Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione s-transferase t1-null and m1-null genotypes. Cancer Epidemiol Biomarkers Prev 9:705-12.
50. Finel M, Li X, Gardner-Stephen D, et al. (2005). Human udpglucuronosyltransferase 1a5: identification, expression, and activity. J Pharmacol Exp Ther 315:1143-9.
51. Food and Drug Administration. (2001). Guidance for industry: bioanalytical method validation. Rockville, USA: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM).
52. Foulds J, Stapleton J, Feyerabend C, et al. (1992). Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berl) 106:421-7.
53. Frederickson SM, Hatcher JF, Reznikoff CA, Swaminathan S. (1992). Acetyl transferase-mediated metabolic activation of n-hydroxy-4- aminobiphenyl by human uroepithelial cells. Carcinogenesis 13: 955-61.
54. Frost-Pineda K, Zedler BK, Oliveri D, et al. (2008a). Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul Toxicol Pharmacol 52:104-10.
55. Frost-Pineda K, Zedler BK, Oliveri D, et al. (2008b). 12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul Toxicol Pharmacol 52:111-17.
56. Fuhr U, Boettcher MI, Kinzig-Schippers M, et al. (2006). Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 15:266-71.
57. Fustinoni S, Soleo L, Warholm M, et al. (2002). Influence of metabolic genotypes on biomarkers of exposure to 1, 3-butadiene in humans. Cancer Epidemiol Biomarkers Prev 11:1082-90.
58. Goniewicz ML, Havel CM, Peng MW, et al. (2009). Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev 18:3421-5.
59. Gregg EO, Fisher AL, Lowe F, et al. (2006). An approach to the validation of biomarkers of harm for use in a tobacco context. Regul Toxicol Pharmacol 44:262-7.
60. Grimmer G, Dettbarn G, Seidel A, Jacob J. (2000). Detection of carcinogenic aromatic amines in the urine of non-smokers. Sci Total Environ 247:81-90.
61. Hatsukami DK, Benowitz NL, Rennard SI, et al. (2006). Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 8:169-91.
62. Hatsukami DK, Hecht SS, Hennrikus DJ, et al. (2003). Biomarkers of tobacco exposure or harm: application to clinical and epidemiological studies. Nicotine Tob Res 5:387-96.
63. Haufroid V, Merz B, Hofmann A, et al. (2007). Exposure to ethylene oxide in hospitals: biological monitoring and influence of glutathione s-transferase and epoxide hydrolase polymorphisms. Cancer Epidemiol Biomarkers Prev 16:796-802.
64. Heavner DL, MorganWT, Sears SB, et al. (2006). Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines. J Pharm Biomed Anal 40:928-42.
65. Hecht SS. (2001). Carcinogen biomarkers ofr lung or oral cancer chemoprevention trials. IARC Sci Pub 154:245-55.
66. Hecht SS, Carmella SG, Chen M, et al. (1999). Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 59:590-6.
67. Hecht SS, Murphy SE, Carmella SG, et al. (2004). Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst 96:107-15.
68. Hecht SS, Yuan JM, Hatsukami D. (2010). Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol 23:1001-8.
69. Hedberg JJ, Backlund M, Stromberg P, et al. (2001). Functional polymorphism in the alcohol dehydrogenase 3 (adh3) promoter. Pharmacogenetics 11:815-24.
70. Himmelstein MW, Turner MJ, Asgharian B, Bond JA. (1996). Metabolism of 1, 3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology 113:306-9.
71. Hoffmann K, Becker K, Friedrich C, et al. (2000). The German environmental survey 1990/1992 (GERES II): cadmium in blood, urine and hair of adults and children. J Expo Anal Environ Epidemiol 10:126-35.
72. Huang C-C, Yang M-H. (1997). Automated online sample pretreatment system for the determination of trace metals in biological samples by inductively coupled plasma mass spectrometry. Anal Chem 69: 3930-9.
73. Huang YF, Chen ML, Liou SH, et al. (2011a). Association of CYP2E1, GST and MEH genetic polymorphisms with urinary acrylamide metabolites in workers exposed to acrylamide. Toxicol Lett 203: 118-26.
74. Huang YF, Wu KY, Liou SH, et al. (2011b). Biological monitoring for occupational acrylamide exposure from acrylamide production workers. Int Arch Occup Environ Health 84:303-13.
75. Institute of Medicine. (2001). Clearing the smoke: assessing the science base for tobacco harm reduction. Washington, DC: National Academies Press.
76. Institute of Medicine. (2010). Evaluation of biomarkers and surrogate endpoints in chronic disease. Washington, DC: National Academies Press.
77. Institute of Medicine. (2012). Scientific standards for studies on modified risk tobacco products. Washington, DC: The National Academies Press.
78. International Agency for Research on Cancer. (2012). IARC monographs on the evaluation of carcinogenic risk to humans. In: Agents classified by the IARC monographs, Vols. 1-104. Available from: http://monographs.iarc.fr/ENG/ Classification/index.php and http:// monographs.iarc.fr/ENG/Classification/ index.php: World Health Organization [last accessed 23 Apr 2013].
79. International Agency for Research on Cancer. (1992). IARC monographs on the evaluation of carcinogenic risk to humans: occupational exposures to mists and vapours from strong inorganic acids; and other industrial chemicals. Lyon: World Health Organization, IARC Publications.
80. International Organization for Standardization. (2005). ISO/IEC17025. General requirements for the competence of testing and calibration laboratories. Geneva: International Organization for Standardization.
81. International Organization for Standardization. (2007). ISO 15189. Medical laboratories - particular requirements for quality and competence. Geneva: International Organization for Standardization.
82. Jarvis MJ, Foulds J, Feyerabend C. (1992). Exposure to passive smoking among bar staff. Br J Addict 87:111-13.
83. Jongeneelen FJ, Bos RP, Anzion RB, et al. (1986). Biological monitoring of polycyclic aromatic hydrocarbons. Metabolites in urine. Scand J Work Environ Health 12:137-43.
84. Kavvadias D, Scherer G, Cheung F, et al. (2009a). Determination of tobacco-specific n-nitrosamines in urine of smokers and non-smokers. Biomarkers 14:547-53.
85. Kavvadias D, Scherer G, Urban M, et al. (2009b). Simultaneous determination of four tobacco-specific n-nitrosamines (TSNA) in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 877: 1185-92.
86. Kedderis GL, Batra R, Koop DR. (1993). Epoxidation of acrylonitrile by rat and human cytochromes p450. Chem Res Toxicol. 6:866-71.
87. Kerzic PJ, Liu WS, Pan MT, et al. (2010). Analysis of hydroquinone and catechol in peripheral blood of benzene-exposed workers. Chemico-Biological Interactions 184:182-8.
88. Kim JH, Stansbury KH, Walker NJ, et al. (1998). Metabolism of benzo[a]pyrene and benzo[a]pyrene-7, 8-diol by human cytochrome p450 1b1. Carcinogenesis 19:1847-53.
89. Kim S, Vermeulen R, Waidyanatha S, et al. (2006). Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. Carcinogenesis 27:772-81.
90. Kimura S, Kawabe M, Ward JM, et al. (1999). Cyp1a2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice. Carcinogenesis 20:1825-30.
91. Kotapati S, Matter BA, Grant AL, Tretyakova NY. (2011). Quantitative analysis of trihydroxybutyl mercapturic acid, a urinary metabolite of 1, 3-butadiene, in humans. Chem Res Toxicol 24:1516-26.
92. Lafontaine M, Champmartin C, Simon P, et al. (2006). 3-Hydroxybenzo[a] pyrene in the urine of smokers and non-smokers. Toxicol Lett 162:181-5.
93. Lazarus P, Zheng Y, Aaron Runkle E, et al. (2005). Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes. Pharmacogenet Genomics 15:769-78.
94. Lee JW, Devanarayan V, Barrett YC, et al. (2006). Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res 23:312-18.
95. Leslie EM, Ito K, Upadhyaya P, et al. (2001). Transport of the beta-oglucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a nonsulfur- containing analog. J Biol Chem 276:27846-54.
96. Li C, Wen D, Zhang J, et al. (2006). Study of the metabolism on tobaccospecific n-nitrosamines in the rabbit by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 386:1985-93.
97. Lindner D, Smith S, Leroy CM, Tricker AR. (2011). Comparison of exposure to selected cigarette smoke constituents in adult smokers and nonsmokers in a European, multicenter, observational study. Cancer Epidemiol Biomarkers Prev 20:1524-36.
98. Lodovici M, Luceri C, Guglielmi F, et al. (2004). Benzo(a)pyrene diolepoxide (bpde)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and MEH. Cancer Epidemiol Biomarkers Prev 13:1342-8.
99. Lu K, Ye W, Gold A, et al. (2009). Formation of S-[1-(N2- deoxyguanosinyl)methyl]glutathione between glutathione and DNA induced by formaldehyde. J Am Chem Soc 131:3414-15.
100. Luukkanen L, Mikkola J, Forsman T, et al. (2001). Glucuronidation of 1-hydroxypyrene by human liver microsomes and human UDPglucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: development of a high-sensitivity glucuronidation assay for human tissue. Drug Metab Dispos 29:1096-101.
101. Manini P, De Palma G, Andreoli R, et al. (2010). Occupational exposure to low levels of benzene: biomarkers of exposure and nucleic acid oxidation and their modulation by polymorphic xenobiotic metabolizing enzymes. Toxicol Lett 193:229-35.
102. Mann SJ, Gerber LM. (2010). Estimation of 24-hour sodium excretion from spot urine samples. J Clin Hypertens (Greenwich) 12:174-80.
103. Mansi A, Bruni R, Capone P, et al. (2012). Low occupational exposure to benzene in a petrochemical plant: modulating effect of genetic polymorphisms and smoking habit on the urinary T, T-MA/SPMA ratio. Toxicol Lett 213:57-62.
104. Martin H-J, Breyer-Pfaff U, Wsol V, et al. (2006). Purification and characterization of AKR1B10 from human liver: role in carbonyl reduction of xenobiotics. Drug Metab Dispos 34:464-70.
105. Mascher DG, Mascher HJ, Scherer G, Schmid ER. (2001). High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. J Chromatogr B Biomed Sci Appl 750:163-9.
106. McElroy JA, Shafer MM, Hampton JM, Newcomb PA. (2007a). Predictors of urinary cadmium levels in adult females. Sci Total Environ 382:214-23.
107. McElroy JA, Shafer MM, Trentham-Dietz A, et al. (2007b). Urinary cadmium levels and tobacco smoke exposure in women age 20-69 years in the United States. J Toxicol Environ Health A 70:1779-82.
108. Meger M, Meger-Kossien I, Riedel K, Scherer G. (2000). Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK). Biomarkers 5:33-45.
109. Menzie CA, Potocoki BB, Santodonato J. (1992). Exposure to carcinogenic PAHs in the environment. Environ Sci Technol 26: 1278-84.
110. Minet E, Cheung F, Errington G, et al. (2011a). Urinary excretion of the acrylonitrile metabolite 2-cyanoethylmercapturic acid is correlated with a variety of biomarkers of tobacco smoke exposure and consumption. Biomarkers 16:89-96.
111. Minet E, Errington G, Scherer G, et al. (2011b). An inter-laboratory comparison of urinary 3-hydroxypropylmercapturic acid measurement demonstrates good reproducibility between laboratories. BMC Res Notes 4:391-6.
112. Muller M, Kramer A, Angerer J, Hallier E. (1998). Ethylene oxide-protein adduct formation in humans: influence of glutathione-s-transferase polymorphisms. Int Arch Occup Environ Health 71:499-502.
113. Muti P, Deutsch A, Freudenheim J, et al. (2000). Why and how to measure urinary sex steroid metabolites in epidemiological studies in women. Nutr Metab Cardiovasc Dis 10:85-91.
114. Nath RG, Ocando JE, Guttenplan JB, Chung FL. (1998). 1, N2- propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. Cancer Res 58:581-4.
115. Nerurkar PV, Okinaka L, Aoki C, et al. (2000). CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev 9:1119-22.
116. Nieusma JL, Claffey DJ, Koop DR, et al. (1998). Oxidation of 1, 3- butadiene to (R)- and (S)-butadiene monoxide by purified recombinant cytochrome p450 2E1 from rabbit, rat and human. Toxicol Lett 95: 123-9.
117. O'Connor RJ. (2012). Postmarketing surveillance for ''modified-risk'' tobacco products. Nicotine Tob Res 14:29-42.
118. Pal A, Hu X, Zimniak P, Singh SV. (2000). Catalytic efficiencies of allelic variants of human glutathione S-transferase PI in the glutathione conjugation of alpha, beta-unsaturated aldehydes. Cancer Lett 154:39-43.
119. Paschal DC, Burt V, Caudill SP, et al. (2000). Exposure of the U.S. population aged 6 years and older to cadmium: 1988-1994. Arch Environ Contam Toxicol 38:377-83.
120. Patten CJ, Smith TJ, Friesen MJ, et al. (1997). Evidence for cytochrome p450 2A6 and 3A4 as major catalysts for n0-nitrosonornicotine alphahydroxylation by human liver microsomes. Carcinogenesis 18: 1623-30.
121. Rahn CA, Howard G, Riccio E, Doolittle DJ. (1991). Correlations between urinary nicotine or cotinine and urinary mutagenicity in smokers on controlled diets. Environ Mol Mutagen 17:244-52.
122. Riedel K, Scherer G, Engl J, et al. (2006). Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol 30:187-95.
123. Roethig HJ, Feng S, Liang Q, et al. (2008). A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a secondgeneration electrically heated cigarette smoking system. J Clin Pharmacol 48:580-91.
124. Roethig HJ, Kinser RD, Lau RW, et al. (2005). Short-term exposure evaluation of adult smokers switching from conventional to firstgeneration electrically heated cigarettes during controlled smoking. J Clin Pharmacol 45:133-45.
125. Roethig HJ, Zedler BK, Kinser RD, et al. (2007). Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. J Clin Pharmacol 47:518-30.
126. Rossi AM, Guarnieri C, Rovesti S, et al. (1999). Genetic polymorphisms influence variability in benzene metabolism in humans. Pharmacogenetics 9:445-51.
127. Ruppert T, Scherer G, Tricker AR, et al. (1995). Determination of urinary trans, trans-muconic acid by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl 666:71-6.
128. Russell MAH. (1976). Low-tar medium-nicotine cigarettes: a new approach to safer smoking. BMJ 1:1430-3.
129. Sarkar M, Kapur S, Frost-Pineda K, et al. (2008). Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies. Nicotine Tob Res 10: 1761-72.
130. Sarkar M, Liu J, Koval T, et al. (2010). Evaluation of biomarkers of exposure in adult cigarette smokers using marlboro snus. Nicotine Tob Res 12:105-16.
131. Sarkar M, Stabbert R, Kinser RD, et al. (2006). CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers. Toxicol Appl Pharmacol 213:198-206.
132. Scherer G. (1999). Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl) 145:1-20.
133. Scherer G, Richter E. (1997). Biomonitoring exposure to environmental tobacco smoke (ETS): a critical reappraisal. Hum Exp Toxicol 16: 449-59.
134. Scherer G. (2005). Biomonitoring of inhaled complex mixtures - ambient air, diesel exhaust and cigarette smoke. Exp Toxicol Pathol 57:75-110.
135. Scherer G, Engl J, Urban M, et al. (2007a). Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul Toxicol Pharmacol 47:171-83.
136. Scherer G, Frank S, Riedel K, et al. (2000). Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol Biomarkers Prev 9:373-80.
137. Scherer G, Renner T, Meger M. (1998). Analysis and evaluation of trans, trans-muconic acid as a biomarker for benzene exposure. J Chromatogr B Biomed Sci Appl 717:179-99.
138. Scherer G, Urban M, Engl J, et al. (2006). Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure. Inhal Toxicol 18:821-9.
139. Scherer G, Urban M, Hagedorn HW, et al. (2007b). Determination of two mercapturic acids related to crotonaldehyde in human urine: influence of smoking. Hum Exp Toxicol 26:37-47.
140. Scherer G, Urban M, Hagedorn HW, et al. (2010). Determination of methyl-, 2-hydroxyethyl- and 2-cyanoethylmercapturic acids as biomarkers of exposure to alkylating agents in cigarette smoke. J Chromatogr B Analyt Technol Biomed Life Sci 878:2520-8.
141. Schettgen T, Musiol A, Alt A, et al. (2009). A method for the quantification of biomarkers of exposure to acrylonitrile and 1, 3-butadiene in human urine by column-switching liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 393:969-81.
142. Schlöbe D, Hölzle D, Hatz D, et al. (2008). 4-Hydroxy-1-(3-pyridyl)-1- butanone-releasing DNA adducts in lung, lower esophagus and cardia of sudden death victims. Toxicology 245:154-61.
143. Seaton MJ, Follansbee MH, Bond JA. (1995). Oxidation of 1, 2-epoxy-3- butene to 1, 2:3, 4-diepoxybutane by CDNA-expressed human cytochromes p450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16:2287-93.
144. Seyler TH, Bernert JT. (2011). Analysis of 4-aminobiphenyl in smoker's and nonsmoker's urine by tandem mass spectrometry. Biomarkers 16: 212-21.
145. Shah KA, Halquist MS, Karnes HT. (2009). A modified method for the determination of tobacco specific nitrosamine 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanol in human urine by solid phase extraction using a molecularly imprinted polymer and liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:1575-82.
146. Shepperd CJ, Eldridge AC, Mariner DC, et al. (2009). A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure. Regul Toxicol Pharmacol 55:97-109.
147. Shimada T, Fujii-Kuriyama Y. (2004). Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes p450 1A1 and 1B1. Cancer Sci 95:1-6.
148. Shimada T, Gillam EM, Oda Y, et al. (1999). Metabolism of benzo[a]pyrene to trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome p450 1B1 and purified liver epoxide hydrolase. Chem Res Toxicol 12:623-9.
149. Smith CJ, McKarns SC, Davis RA, et al. (1996). Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. Mutat Res 361:1-9.
150. St Helen G, Goniewicz ML, Dempsey D, et al. (2012). Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. Chem Res Toxicol 25:952-64.
151. St Helen G, Dempsey D, Wilson M, et al. (2013). Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure. Addiction 108:607-17.
152. Stagos D, Chen Y, Brocker C, et al. (2010). Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme. Drug Metab Dispos 38:1679-87.
153. Stepanov I, Hecht SS. (2005). Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol Biomarkers Prev 14:885-91.
154. Stepanov I, Muzic J, Le CT, et al. (2013). Analysis of 4-hydroxy-1-(3- pyridyl)-1-butanone (HPB)-releasing DNA adducts in human exfoliated oral mucosa cells by liquid chromatography-electrospray ionization-tandem mass spectrometry. Chem Res Toxicol. [Epub ahead of print]. doi: 10.1021/tx300282k.
155. Sterz K, Scherer G, Krumsiek J, et al. (2012). Identification and quantification of 1-hydroxybutene-2-yl mercapturic acid in human urine by UPLC-HILIC-MS/MS as a novel biomarker for 1, 3-butadiene exposure. Chem Res Toxicol 25:1565-7.
156. Suhua W, Rongzhu L, Wenrong X, et al. (2010). Induction or inhibition of cytochrome p450 2E1 modifies the acute toxicity of acrylonitrile in rats: biochemical evidence. Arch Toxicol 84:461-9.
157. Suwan-Ampai P, Navas-Acien A, Strickland PT, Agnew J. (2009). Involuntary tobacco smoke exposure and urinary levels of polycyclic aromatic hydrocarbons in the United States, 1999 to 2002. Cancer Epidemiol Biomarkers Prev 18:884-893.
158. Tan H, Wang Q, Wang A, et al. (2010). Influence of GSTs, CYP2E1 and MEH polymorphisms on 1, 3-butadiene-induced micronucleus frequency in Chinese workers. Toxicol Appl Pharmacol 247:198-203.
159. Tao L, Day BW, Hu B, et al. (2013). Elevated 4-aminobiphenyl and 2, 6- dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers - the Shanghai bladder cancer study. Cancer Epidemiol Biomarkers Prev 22:937-45.
160. Tareke E, Rydberg P, Karlsson P, et al. (2002). Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 50: 4998-5006.
161. Ter-Minassian M, Asomaning K, Zhao Y, et al. (2012). Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (nnk) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (nnal). Int J Cancer 130:1338-46.
162. Thier R, Balkenhol H, Lewalter J, et al. (2001). Influence of polymorphisms of the human glutathione transferases and cytochrome p450 2E1 enzyme on the metabolism and toxicity of ethylene oxide and acrylonitrile. Mutat Res 482:41-6.
163. Thier R, Lewalter J, Selinski S, Bolt HM. (2002). Possible impact of human CYP2E1 polymorphisms on the metabolism of acrylonitrile. Toxicol Lett 128:249-55.
164. Thompson CM, Ceder R, Grafstrom RC. (2010). Formaldehyde dehydrogenase: beyond phase I metabolism. Toxicol Lett 193:1-3.
165. Tricker AR. (2006). Biomarkers derived from nicotine and its metabolites: a review. Beiträge zur Tabakforschung International [Contributions to
166. Upadhyaya P, Zimmerman CL, Hecht SS. (2002). Metabolism and pharmacokinetics of N0-nitrosonornicotine in the Patas monkey. Drug Metab Dispos 30:1115-22.
167. Urban M, Gilch G, Schepers G, et al. (2003). Determination of the major mercapturic acids of 1, 3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 796:131-40.
168. Urban M, Kavvadias D, Riedel K, et al. (2006). Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal Toxicol 18:831-9.
169. US Department of Health and Human Services, Public Health Service, National Toxicology Program (2011). In: Report on carcinogens. 12th ed. Available from: http://ntp.niehs.nih.gov/ntp/roc/twelfth/roc12.pdf [last accessed 23 Apr 2013].
170. van Sittert NJ, Megens JJJ, Watson WP, Boogaard PJ. (2000). Biomarkers of exposure to 1, 3-butadiene as a basis for cancer risk assessment. Toxicol Sci 56:189-202.
171. van Welie RT, van Dijck RG, Vermeulen NP, van Sittert NJ. (1992). Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. Crit Rev Toxicol 22:271-306.
172. Vineis P, Talaska G, Malaveille C, et al. (1996). DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer 65:314-16.
173. Vrisekoop N, den Braber I, de Boer AB, et al. (2008). Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool. Proc Natl Acad Sci USA 105:6115-20.
174. Waidyanatha S, Rothman N, Li G, et al. (2004). Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects. Anal Biochem 327:184-99.
175. Wald NJ, Idle M, Boreham J, Bailey A. (1981). Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax 36:366-9.
176. Wang H, Chanas B, Ghanayem BI. (2002a). Cytochrome p450 2E1 (CYP2E1) is essential for acrylonitrile metabolism to cyanide: comparative studies using CYP2E1-null and wild-type mice. Drug Metab Dispos 30:911-17.
177. Wang M, McIntee EJ, Cheng G, et al. (2000). Identification of DNA adducts of acetaldehyde. Chem Res Toxicol 13:1149-57.
178. Wang M, Cheng G, Balbo S, et al. (2009). Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers. Cancer Res 69:7170-4.
179. Wang R-S, Nakajima T, Kawamoto T, Honma T. (2002b). Effects of aldehyde dehydrogenase-2 genetic polymorphisms on metabolism of structurally different aldehydes in human liver. Drug Metab Dispos 30:69-73.
180. Weiner H, Wang X. (1994). Aldehyde dehydrogenase and acetaldehyde metabolism. Alcohol Alcohol 2:141-5.
181. Weiss T, Angerer J. (2002). Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry. J Chromatogr B 778:179-92.
182. Wiener D, Doerge DR, Fang J-L, et al. (2004). Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDPglucuronosyltransferase 1A4. Drug Metab Dispos 32:72-9.
183. Wong HL, Murphy SE, Hecht SS. (2005). Cytochrome p450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N0-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N- nitrosopyrrolidine. Chem Res Toxicol 18:61-9.
184. Xia Y, McGuffey JE, Bhattacharyya S, et al. (2005). Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal Chem 77:7639-45.
185. Yuan JM, Koh WP, Murphy SE, et al. (2009). Urinary levels of tobaccospecific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res 69: 2990-5.
186. Yuan JM, Gao YT, Murphy SE, et al. (2011). Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res 71:6749-57.
187. Yuan JM, Gao YT, Wang R, et al. (2012). Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis 33:804-9.
188. Zhang S, Balbo S, Wang M, Hecht SS. (2011). Analysis of acroleinderived 1, N2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers. Chem Res Toxicol 24:119-24.
189. Zheng Z, Fang J-L, Lazarus P. (2002). Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 30:397-403.